Application of Biomarkers in the Development of Drugs Intended for the Treatment of Osteoarthritis: OARSI FDA Osteoarthritis Biomarkers Working Group

OBJECTIVE: Osteoarthritis (OA) is a chronic and slowly progressive disease for which biomarkers may be able to provide a more rapid indication of therapeutic responses to therapy than is currently available; this could accelerate and facilitate OA drug discovery and development programs. The goal of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kraus, Virginia Byers, Burnett, Bruce, Coindreau, Javier, Cottrell, Susan, Eyre, David, Gendreau, Michael, Gardiner, Jennifer, Garnero, Patrick, Hardin, John, Henrotin, Yves, Heinegård, Dick, Ko, Amy, Lohmander, Stefan, Matthews, Gloria, Menetski, Joseph, Moskowitz, Roland, Persiani, Stefano, Poole, Robin, Rousseau, Jean Charles, Todman, Martin
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3568396/
https://ncbi.nlm.nih.gov/pubmed/21396468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.joca.2010.08.019
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados